Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 12,754
-42 (-0.33%)
Jan 28, 2026, 12:00 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 164.21 billion as of January 27, 2026. Its market cap has decreased by -10.43% in one year.
Market Cap
164.21B
Enterprise Value
165.16B
Revenue
15.33B
Ranking
n/a
PE Ratio
68.38
Stock Price
12,754.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 164.21B, an increase of 48,896.47%. That is a compound annual growth rate of 27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 164.21B | -15.74% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 337.15B |
| Emcure Pharmaceuticals | 290.20B |
| Gland Pharma | 277.20B |
| Wockhardt | 219.62B |
| Piramal Pharma | 201.05B |
| Eris Lifesciences | 191.94B |
| NATCO Pharma | 149.01B |
| Alembic Pharmaceuticals | 148.86B |